Bio-Rad Laboratories Inc (NYSE:BIO)
$ 294.01 8.57 (3%) Market Cap: 8.31 Bil Enterprise Value: 8.07 Bil PE Ratio: 0 PB Ratio: 0.93 GF Score: 76/100

Bio Rad Laboratories Inc at Jefferies Healthcare Conference Transcript

Jun 04, 2019 / 02:00PM GMT
Release Date Price: $291.8 (+1.24%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Thanks for joining us, everyone. We'll go ahead and get started. Good morning. Welcome to Jefferies 2019 Global Healthcare Conference. I'm Brandon Couillard. I cover Life Science Tools and Diagnostics sector here at Jefferies. Very happy to have Bio-Rad with us back at the conference this year and here to share -- and update with us on the story and the company and all of their progress, CEO, Norman Schwartz. We also have brand-new CFO, Ilan Daskal, with us on here on stage, who will join us downstairs for the breakout afterwards. Norman?

Norman D. Schwartz
Bio-Rad Laboratories, Inc. - Chairman, CEO & President

Okay. Thank you, Brandon. Thank you all for joining us this morning. We're going to take the opportunity this morning to tell you a little bit about Bio-Rad, a little bit about our rich history and how we've contributed to science and health care and where we've been investing and what we see for the future.

Before we get started, I caution you that we will be making

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot